MoonLake Immunotherapeutics (MLTX) Earnings Analysis
MoonLake Immunotherapeutics (MLTX) has no confirmed upcoming earnings date. In its last reported quarter (2026-05-11) MLTX missed analyst consensus (-7.7% EPS surprise). Trailing P/E -4.88.
Last updated 2026-07-23 · Source: company filings + earnings calendar; consensus from sell-side analyst grades
When does MLTX next report earnings?
No confirmed upcoming earnings date is currently scheduled for MLTX. This page updates as the calendar is published.
MLTX last-quarter earnings result
| Last reported quarter | 2026-05-11 |
|---|---|
| Result vs consensus | Miss (-7.7% EPS surprise) |
MLTX consensus estimates and analyst view
Consensus estimates, 8-quarter history and analyst targets are in the SniperIQ app. Create a free account to see them.
Related research pages
More on MLTX
Frequently asked questions
When does MLTX next report earnings?
MLTX has no confirmed upcoming earnings date right now; this page updates as the calendar is published.
Did MLTX beat earnings last quarter?
In its 2026-05-11 report, MLTX missed analyst consensus (-7.7% EPS surprise).
Where can I see MLTX analyst estimates and price targets?
Consensus estimates, 8-quarter history and analyst targets for MLTX are in the SniperIQ app: https://app.sniperiq.ai/register